deltatrials
Recruiting PHASE1 INTERVENTIONAL 3-arm NCT04167696

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02 (CYCLE-1)

Open-label, Phase I, Multi-center Study to Determine in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients the Recommended Dose of CYAD-02 After a Non-myeloablative Preconditioning Chemotherapy Followed by a Potential Consolidation Cycle

Sponsor: Celyad Oncology SA

Conditions Acute Myeloid Leukemia Myelodysplastic Syndrome
Interventions CYAD-02 ENDOXAN Fludara
Updated 8 times since 2019 Last updated: Jun 8, 2020 Started: Nov 25, 2019 Primary completion: Dec 31, 2021 Completion: Feb 28, 2035
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Acute Myeloid Leukemia and Myelodysplastic Syndrome and is currently actively recruiting participants. Celyad Oncology SA leads this study, which shows 8 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Dec 2019 – ~Mar 2020 · 3 months · monthly snapshotRecruiting~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshotRecruiting~Apr 2020 – ~May 2020 · 30 days · monthly snapshotRecruiting~May 2020 – ~Jul 2020 · 2 months · monthly snapshotRecruiting~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshotRecruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – present · 22 months · monthly snapshotRecruiting

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Recruiting PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Recruiting PHASE1

  4. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  5. May 2020 — Jul 2020 [monthly]

    Recruiting PHASE1

▶ Show 3 earlier versions

  1. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE1

  2. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE1

  3. Dec 2019 — Mar 2020 [monthly]

    Recruiting PHASE1

    First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Celyad Oncology SA
Data source: Celyad Oncology SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations